Become a logicalchat Member

Latest Post

Will Mortgage Rates Go Down in 2025 in Canada?

In recent years, mortgage rates in Canada have been a topic of concern for many homeowners and potential buyers. With rising interest rates, many...

Your story starts here. Sign up and let's connect in ways that truly matter!

HomeValue stockGrowth Investing101: Andlauer Healthcare Group Inc. (AND)

Growth Investing101: Andlauer Healthcare Group Inc. (AND)

AND

Fundamentals Analysis:

Company Overview:

  • Established in 1991 and situated in Vaughan, Canada.
  • Traded publicly on the Toronto Stock Exchange using the ticker symbol AND, boasting a market capitalization of $1.75 billion.
  • A prominent and growing enterprise in supply chain management.
  • Expert in providing customized logistics and specialized transportation services for the healthcare industry across Canada and the United States.”
  • Core services include packaging, transportation, and distribution of temperature-controlled medicines..

Key Reasons to Invest in [Andlauer Healthcare Group Inc]

  • With a debt-to-equity ratio of 0.27 and total debt of $127.9 million, balanced against cash reserves of $59.74 million, the company demonstrates sound financial management.
  •  Impressively, it achieves a ROIC of 11.53% and ROE nearing 15%, indicating efficient capital utilization.
  • A dividend yield of 0.85% offers additional value to investors.
  • Additionally, its strong profitability ratios indicate solid margins, with gross margins at 24.18% and net margin at 10.98%, outperforming industry standards
  • Andlauer Healthcare Group Inc. excels in delivering temperature-controlled medicines, a niche market with high demand.
  • The company collaborates with major pharmaceutical companies like Pfizer and Teva, as well as leading distributors such as Shoppers and London Drugs, strengthening its market presence.
  • Moreover, consistent revenue growth underscores the company’s stability and potential for further expansion.

Risk Factors:

  • Competition and Innovation: Andlauer Healthcare Group Inc. competes with larger players like McKesson Corporation and must innovate to stay competitive.
  • Investment Caution: Investors should be cautious as the company appears relatively high-priced compared to its earnings and assets, with a high EV/EBIT ratio of 18.98 and P/E ratio of 27.40.

Chart

= The stock is currently trading 24% below its all-time highs.

=  If the stock breaches the support level of $37.50, it could potentially trigger additional downside momentum.

= When the downside is triggered, we will have the opportunity to buy the stock with a margin of safety.

To get regular updates on stocks, please join our Discord community.

Our Articles on Long-Term Stock Analysis My best read on trading is this Book

Related Post